Research Article
ELISA Development for Serum Hemeoxygenase-1 and Its Application to Patients with Acute Respiratory Distress Syndrome
Figure 4
Comparison of patients according to serum HO-1 concentrations. The 28-day survival was significantly better in the low serum HO-1 group () than in the high serum HO-1 group () (). HO-1, hemeoxygenase-1.